Investing Profile

Stephen Knight

InvestorVC
President and Managing Partner at F-Prime Capital Partners
fprimecapital.com/people/step...Cambridge, Massachusetts
Photo of Stephen Knight, Managing Partner at F-Prime Capital Partners
cb
F-Prime Capital Partners Managing Partner
$100K - $10.0M
$5.0M
15
CompanyStageDateRound SizeTotal Raised
Quantum Circuits
Series BMay 2024$60M
$78M
Co-investors: Bill Coughran (Sequoia Capital), Brendan Dickinson (Canaan Partners), Eugene Chiu (In-Q-Tel), Corey Ritter (ARCH Venture Partners)
Genomics
Series CJan 2024$45M
Series UnknownMar 2021$30M
Series BDec 2018$9M
$84M
Co-investors: Jim Tananbaum (Foresite Capital)
Paradigm
Series AJan 2023$200M
$240M
Co-investors: Hemant Taneja (General Catalyst), Ramnik Arora (FTX Ventures), Elena Viboch (General Catalyst), Bilal Zuberi (Lux Capital), Brett Cook (F-Prime Capital Partners), Jared Friedman (Y Combinator), Robert Nelsen (ARCH Venture Partners), Jay Markowitz (ARCH Venture Partners), Alaa Halawa (Mubadala), Scott Belsky, Eoghan McCabe, Arash Ferdowsi
Ensoma
Series BJan 2023$85M
Series AFeb 2021$70M
$210M
Co-investors: Kush Parmar (5am Ventures), Kouki Harasaki (Bioluminescence Ventures), Mark Chin (Arix Bioscience)
Aerium Therapeutics
Series AMar 2022
Co-investors: Michael Powell (Omega Funds), Vincent Ossipow (Omega Funds)
Leyden Labs
Series BJan 2022$140M
Series AMar 2021$47M
$260M
Co-investors: David Schenkein (GV (Google Ventures)), Nisa Leung (Qiming Venture Partners), Brook Byers (Kleiner Perkins)
Prime Medicine
Series BJul 2021$200M
Series AOct 2019$120M
$320M
Co-investors: David Schenkein (GV (Google Ventures)), Robert Nelsen (ARCH Venture Partners), Neil Sirni (Arrive), Stephen Francis (Arrive)
Atalanta Therapeutics
Series AJan 2021$110M
$110M
Co-investors: Stacie Weninger (F-Prime Capital Partners), Jessica Alston (F-Prime Capital Partners)